[Tyr0]-C-Peptide, human adds an N-terminal tyrosine to the native connecting peptide, offering a chromophoric and labeling site. The modification preserves the core sequence used in proinsulin processing studies. Researchers employ this analog to monitor peptide-receptor interactions and conformational changes. Its design supports fluorescence-based and structural investigations in peptide biology.
CAT No: C31005
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More